Markets › India › NSE › SAILIFE

Sai Life Sciences Ltd

NSE:SAILIFEHealthcareNSE:CNX500NSE:CNXPHARMA

₹1,395.90+0.47%At closeAt close · Mon 19 Oct · ≈ AED 53.86 · Market cap $3.13B · Next earnings Thu 5 Nov

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	13.3%	13.3%	12.5%	19.7%	36.5%	35.2%	—	—
Operating margin	—	4.2%	4.3%	12.1%	16.1%	21.2%	21.2%	+0.0 pts
Net margin	0.7%	0.7%	0.8%	5.6%	10.0%	15.9%	15.9%	+0.0 pts
EBITDA margin	14.6%	14.6%	12.6%	20.3%	26.1%	30.7%	—	—
Return on equity	—	0.7%	1.1%	8.5%	8.0%	14.0%	14.0%	+0.0 pts
Return on assets	0.3%	0.3%	0.5%	3.6%	5.4%	9.6%	9.6%	+0.0 pts
Return on capital employed	—	2.5%	3.6%	11.6%	11.3%	16.6%	—	—
Debt / equity	—	1.1×	1.1×	1.0×	0.2×	0.1×	0.1×	+0.0%
Debt / assets	44.6%	44.6%	42.7%	40.8%	11.2%	8.0%	—	—
Interest coverage	0.0×	0.7×	0.6×	2.0×	3.5×	11.8×	—	—
Current ratio	—	1.3×	1.3×	1.3×	2.1×	1.7×	1.7×	+0.0%
Quick ratio	—	1.1×	1.1×	1.2×	1.9×	1.5×	—	—
Cash ratio	—	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.4×	0.4×	0.5×	0.6×	0.5×	0.6×	—	—
Inventory turnover	—	5.5×	7.1×	12.7×	10.7×	9.4×	—	—
Receivables turnover	—	1.8×	2.4×	2.5×	2.2×	5.9×	—	—
Dividend payout	—	0.0%	0.0%	0.0%	0.0%	0.0%	—	—